Writing
Essays & commentary
The complete archive, newest first. Use the two filters to narrow the chronology by intellectual territory or place.
Showing 76 essays
My AI Personal Health Dashboard Surprised Me
I brought ten years of medical reports, wearable data, training records and personal notes into one AI-assisted health dashboard. What became visible changed my conversations with health professionals, and my view of what AI health companies can defensibly sell.
Read essay →Small Is Better: Why the Gulf’s Diagnostics Sovereignty Moment Demands the Right Architecture
A few years ago, as I was exploring relocating my company to a Gulf country, I sat with the innovation lead of a regional development programme. He was visibly excited as he described how a major diagnostics multinational had committed to building a presence in his country: investment, jobs, a regional hub. The whole language…
Read essay →What My 92-Year-Old Father Is Teaching Me About Longevity Medicine
This is a personal story about longevity medicine seen from the waiting room, framed by the WHO concept of intrinsic capacity and by a life split between Barcelona and the Gulf. A Personal Prelude I don’t think we can truly understand the abstraction of “healthcare infrastructure” until it knocks on our door. Recently, I lost…
Read essay →The Plasticware Paradox
A Blackout, Toilet Paper, and GCC Diagnostics How the Gulf exports the raw material for molecular medicine, and imports every finished piece of it The Gulf Cooperation Council (GCC) has invested heavily in genomics, cancer care, and national screening programmes, but the region’s diagnostics manufacturing base remains thin. This essay argues that single-use laboratory plasticware…
Read essay →Reflections on BGI’s Gulf Partnerships: Localisation Is Not Sovereignty
As the Strait of Hormuz crisis intensifies and persists, major container lines have suspended or rerouted Gulf calls around the Cape of Good Hope, adding ten to fourteen days to deliveries of medical devices, consumables, and diagnostic inputs. Freight and insurance costs spiked. Airspace restrictions compounded the disruption: medical and humanitarian supplies including IV fluids,…
Read essay →The Localisation Trap: GCC Needs a Regional Diagnostics Strategy, Not Six National Ones
Over the past several weeks I have been reading the many analyses coming out of Gulf policy circles. Carnegie’s three scenarios for GCC states after the Iran war. The Al Jazeera opinions arguing that joint defence and integrated development are now the only credible regional agenda. The Middle East Council’s assessment of Qatar’s strategic position…
Read essay →Saudi Arabia’s quiet LDT move is bigger than it looks
The MDS-G022 lays the foundation for a GCC-wide in-house IVD framework. This matters for diagnostics sovereignty and early commercial development in the Gulf In May 2025, the Saudi Food and Drug Authority published Version 2.0 of MDS-G022, its guidance on in-house IVDs. Most commentary has treated it as a compliance update for lab managers. I want…
Read essay →The Validation Tax
A note from work in progress: The Import Condition: Diagnostics, Sovereignty, and the Gulf’s Industrial Moment There is a dependency in Gulf healthcare that does not appear on any customs manifest and generates no import tariff. It does not show up in the trade statistics for diagnostic reagents. It cannot be measured in tonnes at…
Read essay →What Does Your Tuesday Look Like in 2029?
“The purpose of a thought-experiment … is not to predict the future … but to describe reality, the present world.” – Ursula K. Le Guin A few weeks ago I watched a video of a humanoid robot learning to fight. A Chinese-made bipedal machine, trained by reinforcement learning, discovering how to destabilise another bipedal opponent….
Read essay →Magnificent Hospitals, Empty Supply Chains: The case for diagnostic sovereignty in the Gulf
Published on Linkedin on April 5, 2026 A simple blood count is not a glamorous, high-tech, innovation-driven precision medicine, AI-powered solution. It is not the next shiny thing that makes investors and bureaucrats alike very excited. Yet every hospital in the Gulf runs hundreds, maybe thousands of them every day. Haematology panels, biochemistry screens, urine…
Read essay →On Dignity, and a Medicine That Seems to Have Forgotten It Treats People
A visit to Sant Joan de Déu in Barcelona showed me that the most advanced medicine can remain centred on comfort, vulnerability and the dignity of the person.
Read essay →Precision Diagnostics in Saudi Arabia? The beauty of Scale
by Jose Leal, 5th December 2025 Where should we build the next stage of our work? This question has been driving my thinking about the Gulf for the past year. As Ophiomics moves from clinical validation into manufacturing and regional deployment, I need to understand not just market sizes or tender processes, but what each country’s…
Read essay →Qatar’s Precision Diagnostics Opportunity: From Research Excellence to Industry Leadership
Why Qatar can – and must – claim the diagnostics translation space before regional competitors occupy it By José Pereira Leal, PhD Published on Linkedin on Dec 4th, 2025. Over the past year, I’ve been reflecting – and occasionally writing here – on why I believe the countries of the Gulf Cooperation Council are building…
Read essay →The 60-Million+ Patient Passport: Why the GCC Needs a “Gulf CE Mark”
Published on LinkedIn on Dec 1st, 2025 In the global race for medical innovation, market size matters, but market access matters more. Today, a medical device manufacturer targeting the Gulf Cooperation Council (GCC) faces a paradoxical reality. They (we!) see a wealthy, integrated economic bloc of 60+ million people with world-class healthcare infrastructure. Yet, when…
Read essay →Beyond Engineers and Lawyers: A Third Path for Precision Medicine
Published on Linkedin on Nov 23rd I visited Wuhan once, in 2004, teaching for a couple of weeks as part of EMBO’s World Program. I can’t claim the trip left me with profound insights about China – the city was unremarkable if enormous, nothing that prepared me for what it would become or mean to…
Read essay →Rebuilding the Case for Diagnostics Investment (2/2): A Framework for Investors
Published on LinkedIn on Nov 20th In Part 1/2 (https://www.linkedin.com/pulse/rebuilding-case-diagnostics-investment-12-reflections-pereira-leal-swvbf), I discussed why diagnostics face a systematic funding gap despite being essential infrastructure for precision medicine, and outlined five strategic directions for entrepreneurs building diagnostic companies. Those reflections emerged from building Ophiomics and follow from the reflection I’ve been making for my book, Precision Diagnostics:…
Read essay →Rebuilding the Case for Diagnostics Investment (1/2): Reflections and Notes for Founders
Published on LinkedIn on Nov 17th The diagnostics sector faces a paradox: we’re living through a precision medicine revolution, yet the tools that make precision medicine possible remain chronically underfunded. In 2023-2024, diagnostics captured just $2.2 billion in global venture funding, while AI companies raised over $100 billion globally in 2024. Even within healthcare, nearly…
Read essay →On WebSummit 2025
Published on linkedin A few days after Web Summit Lisbon 2025, one impression remains very clear to me: how differently national hashtag#innovationecosystems choose to present themselves. As someone working at the intersection of precision diagnostics and ecosystem development, I pay attention not only to the technologies on display but to the systems behind them. One of the…
Read essay →Qatar’s Precision Medicine Leap: From Vision to Innovation Economy
Published on Linkedin on November 8th, 2025 Reading Qatar’s latest precision medicine and national strategy reports as my flight approached Doha, I found myself genuinely impressed and, as a veteran of biomedical strategy, more than a little astonished. In barely a generation, Qatar has accomplished what it has taken the world’s leading medical innovation centers…
Read essay →Reflecting on Barcelona’s Ecosystem: Twenty-Odd Years of Convergence
Published on Linkedin on October 12, 2025 I just spent three intense days at BioSpain 2025 (https://www.asebio.com/en/news-events/news/biospain-2025-closes-record-attendance-and-passes-baton-bilbao-2026-host-city), participating in a most intense (!) partnering marathon, and also had the privilege of participating in two roundtables. One, wearing the hat of VP of P-BIO (https://p-bio.org), was entitled “𝘍𝘳𝘰𝘮 𝘙𝘦𝘨𝘪𝘰𝘯 𝘵𝘰 𝘎𝘭𝘰𝘣𝘢𝘭: 𝘉𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘚𝘤𝘢𝘭𝘢𝘣𝘭𝘦 𝘉𝘪𝘰𝘵𝘦𝘤𝘩 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘧𝘪𝘤…
Read essay →Precision Medicine Isn’t Elitist: It’s the Only Equitable Option
At 35, Sarah suffered a heart attack that a €30 genetic test could have prevented. Her story isn’t unusual, it’s a mirror of how health systems worldwide confuse “standard care” with equity. Sarah, a 34-year-old teacher, had visited her GP complaining of fatigue and chest tightness during exercise. Her cholesterol was significantly elevated at 8.2…
Read essay →Europe’s Genomic “Ambition” (?): The Transparency Test
The European Union proclaimed its 1+ Million Genomes initiative in April 2018, with 26 Member States committing to create federated genomic infrastructure. Six years later, we can’t even determine how many genomes Europe has actually sequenced. 🇪🇺 EU 27 Countries: ??? genomes completed – No consolidated reporting after 6 years Try finding the actual genome…
Read essay →The Diagnostic Timing Trap
“70% of clinical decisions depend on diagnostics.” You’ve seen this statistic, but it hides an important detail: timing. The acuity gradient: Lab testing occurs in 98% of inpatient encounters, 56% in emergency departments, but only 29% in outpatient settings (Ngo et al., 2017): diagnostics concentrate where disease is most advanced. Prevention is neglected: Evidence-based guidelines…
Read essay →The Liver – Longevity Connection: Why Precision Liver Medicine Deserves a Seat at the Longevity Table
Published on Linkedin on August 3rd, 2025 While everyone chases longevity drugs, the real fountain of youth sits in your liver In the ever-expanding dialogue around longevity in a medical setting, we hear a lot about telomeres, senescence, mitochondrial decline, DNA repair, VO2 Max, stem cells and, unfortunately, an endless stream of pseudo-science powering rising…
Read essay →If Precision Medicine Is the Future, Why Are We Neglecting Its Foundation?
published on Linkedin on 20 July 2025. Every week, my LinkedIn feed is filled with billion-dollar AI alliances, breakthrough biomarker announcements, and government blueprints for “future healthcare.” Locally and globally, the numbers are extraordinary: the global precision medicine market is set to reach USD 119 billion in 2025 and leap to USD 470 billion by…
Read essay →From Promising to Proven: Lessons from the Validation Trenches of Biomarker Development
Published on linkedin on June 17th 1. Not enough evidence! When we first embarked on developing Hepatopredict, our idea was very clear: create a biomarker-based test that could reliably inform clinical decisions about liver transplantation in patients with hepatocellular carcinoma (HCC). In our minds, the pathway was straightforward: demonstrate a strong correlation with clinical outcomes,…
Read essay →Liver Transplantation Enters the Era of Precision Diagnostics
Published on MedEdgeMEA on May 31th Introduction: A New Frontier for Liver Transplantation Precision medicine has transformed fields like oncology and cardiology, but liver transplantation has been left behind. Despite being a domain where decisions often mean life or death, the field still relies on outdated clinical scoring systems. But this is changing. The tools…
Read essay →Salty rivers into the desert: How Saltwater Canals Could Transform UAE Deserts into Climate-Resilient Food Systems
By José Pereira Leal To the memory of Gordon Hisashi Sato (1927–2017), Scientist extraordinaire who inspired me, and many others, to imagine new rivers through the desert. Like many of his generation who witnessed the horrors of World War II, he dedicated his science and life to the service of humanity Image created with ChatGPT…
Read essay →Turning Precision Medicine from Ambition to Impact: Reflecting on a Liver Health Vertical in the UAE
This reflection was heavily reliant on sourcing information and testing arguments with my favourite AI agent: Perplexity.AI. The ideas, interpretations, and conclusions are mine. The estimates on impact (e.g., life-years gained, cost savings) are approximations and should be taken with a grain of salt. Finally, I did my best to make sure no ‘source hallucinations’…
Read essay →Why the GCC Is Suddenly on My Precision Medicine Map
this was published as an article on Linkedin and copied here. As an entrepreneur in precision medicine, I keep worrying about where can my AI-powered, precision liver medicine agenda truly find a home? It’s not just a strategic exercise-though the availability of investment, the spirit of innovation in medical communities, regulatory frameworks, the appetite for…
Read essay →Precision Medicine Needs a Human Touch
I’ve followed Abu Dhabi Health Week from afar, and I find myself still thinking about the energy and optimism that surrounded the conversations on precision medicine and longevity. There’s something exhilarating about seeing the future of healthcare come to be—AI, genomics, new therapeutics, all promising to help us live longer, healthier lives. It’s hard not…
Read essay →Some Thoughts on Developing Biomarkers into Diagnostic (Dx) Innovation
This post was motivated by my experiences advising startups, participating in acceleration programs, and working with academic research groups. Over the years, I’ve seen the challenges of translating biomarker discoveries into impactful diagnostic products, and I hope to share some lessons learned to help others navigate this complex but rewarding journey. Note on AI usage:…
Read essay →Entrepreneurship is a team sport
The virtual space is now flooded with people labeling themselves with the hashtag #speaksabout and #keynotespeaker. Everybody is an expert seeking to share views, experience, expertise, even if these don’t amount to much. There are a plethora of books out there teaching you the secrets to becoming a “Highly Paid Expert” (actual title of one…
Read essay →Innovation Juri at the Faculty of Science
I had the pleasure to participate in a Juri for the first edition of the Internal Competition for Science Innovation Projects at the Faculty of Science, University of Lisbon, a process which concluded with a final event on January 18th. I’ve seen impressive projects and wish the best success to all the teams involved. The…
Read essay →Discussing innovation in biomarkers at the Is3 annual retreat
I had the opportunity of discussing the trials and tribulations of developing biomarkers into clinically relevant products with the researchers of I3S, the largest Biomedical Research Institution in Portugal, during they annual retreat. It was fun to meet old friends, make new ones, and experience the most intense almost-until-dawn karaoke session. I’m told that what…
Read essay →In defense of a Scale Up Portugal program
Opinion published (in Portuguese) on the national newspaper Diário de Notícias where I defend the need for a scale up strategy for Portuga. A consistent, bi-partisan effort to support entrepreneurship is steadily resulting in an abundance of start ups; now we need to help them go global: Venha daí uma estratégia de ‘Scale up’ para…
Read essay →Participation € Bitalk podcast on Genetic Manipulation and DNA
I had the honor of spending a couple of hours discussing with the father/soon duo José Serra/Tocha for the Bitalk podcast about… well, it started with genetics and then it went on all sort of directions. It was fun, thank you for the invite.
Read essay →Round table on Innovation on the 112th aniversary of the Faculty of Sciences
I had the privilege to participate in a round table about collaborations between academia and industry promoted by Tech Labs during the celebration of the University of Lisbon’s 112th anniversary. A panel of people with different backgrounds (VC, Corporate, Start Ups) had strikingly different views, which I guess promises diverse possibilities of making this collaboration…
Read essay →Discussing Precision Medicine in Oncology
I presented the development of HepatoPredict and our experience of translating discoveries on biomarkers into clinically relevant ready to use products at the meeting Precision Medicine in Oncology In Porto. Thank you Nuno value for the invitation.
Read essay →In defense of Molecular Diagnostics innovation and manufacture as a relevant sector for Portugal
Opinion published (in Portuguese) on the national newspaper Diário de Notícias where I defend the need that the discovery and manufacture of innovative Molecular Diagnostics (In Vitro Diagnostics Medical Devices) should be a priority for academia, Government and Investors, considering the current landscape of R&D and Investment capability. I believe that focusing on this sector…
Read essay →Interview to OeirasValley on the occasion of BioMeet 2022
An interview to Oeiras Valley about Biotechnology and its promises and relevance to Portugal, the Portuguese Biotech association and the collaboration with the Oeiras Municipality.
Read essay →Joining NOVA’s Innovation mentors
I am happy to share that I now integrate Universidade Nova innovation mentor network to support their scientists and innovators in their innovation and entrepreneurial journey. I’ve mentored multiple projects since I worked as scientific director of Healthcare City, a project that was promoted by NOVA’s Medical School. I am excited to collaborate again with…
Read essay →Interview for BioData.pt on the origins of CorkOakDB
Reminiscing about how we set up the first Genomic Database for the Cork Oak.
Read essay →Who will lead the adoption of an IoT/Robotic/AI medicine?
I have had this conversation over and over again, so I decided to lay out some arguments here. I am convinced that we are on the brink of a major change in the way medicine is practiced for two reasons. The first, which I will leave for another occasion is the empowerment of the individual…
Read essay →The future of education of health professionals – 1
health schools need to get their act together quickly and focus on training for the PRESENT of nutrition science, and not for its past.
Read essay →New drugs for biodefense with bioinformatics
Years ago I supervised a research project on genome reduction in bacteria, in obligate intracellular parasites and endosymbionts. We (myself, André Mendonça and Renato Alves), after an extensive exercise in genome data analysis and genome evolution modelling, realised that environmental predictability was a major force driving genome reduction. To this day, this is probably the…
Read essay →Genealogia “tech”: recursos digitais e ideias de negócio
Muitos saberão que eu tenho o vício da genealogia. Para os que pública ou discretamente o partilham, deixo uma informação útil. Os 12 volumes da obra Portugal Antigo e Moderno – de Pinho Leal foram digitalizado pela Universidade de Toronto. Também o Portugal Sacro -Profano, de Paulo Dias de Niza foi digitalizado. Estes são catálogos…
Read essay →Speaker: Big Data & Oncology
If there is one filed of Medicine where AI is already showing greatest impact is Oncology. Last Thursday I was at the Encontros da Primavera, in Évora, discussing the challenges of big data and examples of AI applications in Oncology, sharing the stage with Sofia Rocha. We had a lively discussion with an audience of…
Read essay →Speaker: Big Dat, AI and Medicine
Last Saturday I was at Culturgest discussing Big Data and Medicine with Joana Sá (NOVA SBE), Elsa Cardoso (ISCTE) in a session organised by Davide Scarso and moderated by Hugo Almeida, both from the Centro Interuniversitário de História das Ciências e da Tecnologia. While the panel covered different topics – potentials and pitfalls, what I…
Read essay →Speaker: Microbiome manipulation
I was yesterday at the annual meeting of the Associação Portuguesa de Nutrição Entérica e Parentérica discussing with an audience largely composed by nutritionists the routes and clinical evidence for microbiome manipulation. It is yet another dimension that we investigate in our attempt to understand our health, one that raises important challenges to he health…
Read essay →Speaker: AI (WfG) in Medicine
I participated in the session 1,000,000 genome initiative in 2019’s Portugal eHealth Summit. I discussed the role of AI in the clinical genomics laboratory, and the specific case of the adoption of the AI platform Watson for Genomics at the Centro de Medicina Laboratorial Germano de Sousa, together with the IBM’s Cristina Semião. The growing…
Read essay →Speaker: Big Data and automation in medicine
I gave a talk at the Escola Superior de Tecnologias da Saúde, a school that trains for many of the health professions, such as physiotherapists, opticians, nutritionists, pathology technicians, etc. I Discussed:
Read essay →About HepatoPredict on HealthEuropa
I had the opportunity to answer some questions for Health Europa about a tool we are developing to help liver cancer paints in finding the best treatment, in particular to ascertain their eligibility for curative intent surgical treatments. HepatoPredict: stratifying liver cancer patients for transplantation
Read essay →Speaker: precision medicine in Astma
I gave a talk about genomics and the development of precision medicine approaches in Asma at the ASIA meeting 2018 (Associação de Serviços e Unidades de Alergologia). I discussed the challenges of establishing a genomics-based precision medicine approach to asthma, from the determination of a priori risks from one’s genetic backgrounders, to the study of…
Read essay →Speaker: The future of the family doctor
I gave a talk at the 23ªS JORNADAS DE CARDIOLOGIA EM MEDICINA GERAL E FAMILIAR, in Algarve, Olhão, Hotel Real Marina, in a session on Personalised Medicine organised by. Prof. Germano de Sousa. I discussed the present and future role of the family doctor in face of changing trends in medicine. On one hand technology…
Read essay →A genómica dos tumores sólidos e o papel da biópsia tissular e líquida
A GENÓMICA DOS TUMORES SÓLIDOS E O PAPEL DA BIÓPSIA TISSULAR E LÍQUIDA O cancro é considerado uma doença genómica, em que alterações no ADN do tumor geram uma multiplicação descontrolada das células. Este comportamento invasivo origina a metastização e a resistência a fármacos tornando a terapêutica ineficaz…
Read essay →Discussing Career Paths with Scientists at Careers Forum
I had the opportunity to discuss the trials and tribulations of moving from academia to becoming an entrepreneur with scientists attending the Career Opportunities forPostDoctoral Researchers inLife Sciences meeting in Cascais. I hope it was informative and maybe even inspiring. We need scientists to get out of their comfort zone to come out and change the world!
Read essay →Speaker: Investment & Innovation potential in Life Sci.
On Nov 16th, 2017 I gave a talk at the I annual meeting of the Associação de Consultores de Investimento e Inovação de Portugal about the Potential for Investment and Innovation of the Life Sciences. I discussed changing trends in Biomedical sciences and the health sector, and the opportunities arising. I also discussed the Portuguese…
Read essay →Diário de Notícias interview
An article at the national Diário de Notícias about liquid Biopsies in 2017 discussing Liquid Biopsies. The Journalist “forgot” to mention Ophiomics – Precision Medicine, where we have been performing liquid biopsies for years now, within a clinical context, supporting medical decision-making in advanced cancers.
Read essay →Entrevista RTP1
No Bom dia Portugal da RTP1 a explicar o que são biópsias líquidas. O vídeo pode ser visto aqui (entrevista começa no minuto 23:25)
Read essay →Entevista – SAPOLifestyle
BIÓPSIA LÍQUIDA, O “SANTO GRAAL” DA MEDICINA QUE É BARATO E EFICAZ NA DETEÇÃO DO CANCRO A biópsia líquida é um exame médico padronizado que tem ganho atenção científica mas também mediática pelas suas potencialidades na deteção precoce de várias doenças, nomeadamente as patologias oncológicas. Estivemos à conversa com o investigador José Leal, diretor executivo…
Read essay →Entrevista – Pontos de Vista
Intrevista para a revista Pontos de Vista. Medicina de precisão: a saúde do paciente de uma forma exclusiva A medicina, tal como em outras áreas, encontra-se em constante mutação e jamais cessa a sua busca por novos tratamentos, metodologias e soluções. O potencial da Medicina de Precisão é enorme, conceito que permite entender por que…
Read essay →Entrevista – News Farma
A biópsia líquida é “uma abordagem tecnológica recente que nos permite aceder a tumores que, de outro modo, seriam difíceis de aceder” e “tratar o doente oncológico de uma forma mais completa” do que até então. As palavras são do Dr. José Leal, do Centro de Medicina Laboratorial Germano de Sousa – Ophiomics, que, em…
Read essay →O projecto Healthcare City – Incubação de valor acrescentado no setor da saúde.
O empreendedorismo tem sido uma marca da nossa história recente, e já em 2001 e 2007 Portugal estava no top da lista das nações mais empreendedoras da Europa (como demonstra, por exemplo, esta tese de doutoramento da Daniela Pacheco Moura). Não será alheio a este sucesso a proliferação de incubadoras de negócios e de programas…
Read essay →Biomarkers that predict Barrett’s oesophagus malignant progression
A new paper was just published by my Computational Genomics Group at the Instituto Gulbenkian de Ciência – CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant Progression. This was a collaborative study with clinicians from the the Lisbon Cancer Centre (Instituto Portugues de Oncologia de Lisboa), funded by a grant…
Read essay →Sobre a criação de Centros de Transferência de Tecnologia em Portugal – Necessidade e Oportunidade
O problema da escassa transferência para a sociedade e economia que a nossa ciência e tecnologia tem operado é sobejamente conhecido e debatido, não obstante o nível de excelência e projeção internacional que conquistou em varias áreas. O European Innovation Scoreboard da União Europeia para Portugal ilustra bem este ponto, mostrando que Portugal tem uma…
Read essay →Porque os doutorados em ciências da vida não vão montar empresas de biotecnologia?
Tenho a percepção que que poucos doutorados em ciências da vida em Portugal estão a sair da academia para ir montar empresas, e é sobre este tema, que me preocupa, que escrevo este post. Esta declaração não é quantitativa nem baseada numa análise sistemática e profunda de todos os casos de empreendedorismo em Portugal, mas…
Read essay →BolaTV interview
At BolaTV chating to Marina Caldas about Liquid Biopsies, with Dr. José Germano de Sousa from Centro de Medicina Laboratorial Germano de Sousa, as part of my activty at Ophiomics – Precision Medicine – we discussed clinical genomics, liquid biopsies, research and clinical opportunities of lhes novel technologies, as well as ethical and cost issues associated with precision medicine. The…
Read essay →On writing theses and other research documents
Over more than ten years as a group leader and mentor to multiple students and postdocs, and more than 20 years as a scientist who publishes research papers regularly, I came to realize that writing is one of he major problemas that aspiring scientists have. Writing research papers, thesis, progress reports for funding agencies or…
Read essay →Rab GTPases in Archaea
A new paper was just published by my Computational Genomics Group at the Instituto Gulbenkian de Ciência in the prestigious journal Molecular Biology and Evolution, showing that the small GTPases in the newly found Archaeal phylum have many Rab-like properties, and that by co-existing with REP/GDI-like molecules, they allow us to propose that the interaction between Rabs and REP/GDIs proceeded the emergence…
Read essay →Pharma Boardroom Interview
Interview for Pharma Boardroom, discussing the Institute Gulbenkian de Ciência – Fundação Calouste Gulbenkian.
Read essay →Interview – Sic Notícias
Interview in the news channel SIC Notícias for “Programa da manhã”, on 11.11.2011, about Bioinformatics in Cancer Research, in the context of the Harvard Medical School Portugal Program.
Read essay →Movimento Ciência Portugal – 2011
Following the election of new government, and at the onset of a major financial crisis that lasts to these days, some of us (scientists) were very worried by a shift in funding of science from basic to applied. It was (and is) our conviction that without a solid foundation in basic science no disruptive innovation…
Read essay →On Translating Bioinformatics for the economy
Presenting at the Ciência 2010, a national science showcasing initiative by FCT and other governmental agencies, about “TRANSLATING BIOINFORMATICS RESEARCH FOR HEALTH, BIOTECH AND THE ECONOMY“, at the Bioinformatics and Computational Biology session.
Read essay →Interview/Debate at 4xCiência
At the 4xCiência Show, hosted by Sandra Inês Cruz, discussing Bioinformatics with Prof. Arlindo Oliveira (IST) and Prof. José Guedes de Oliveira (INESC TEC)
Read essay →Interview/Debate – Falar Global
At the Falar Global show, discussing with Reginaldo Rodrigues de Almeida new technologies in medicine, like genomics and bioinformatics, and the future (and present) of medicine
Read essay →
No essays match both filters.